RTW Biotech invests in EUR65 million Alesta Therapeutics round
(Alliance News) - RTW Biotech Opportunities Ltd said on Friday said it is participating in a EUR65 million Series A financing round for Alesta Therapeutics BV, a Leiden, Netherlands-based ...
Second half of Alan Jackson’s farewell tour resumes next week: Where to buy tickets
The second half of Alan Jackson’s farewell tour resumes next week. The country music legend will perform on Saturday, Jan. 18 ...
Taste of Country2d
Alan Jackson Fan Scammed Out of Almost $3K by Online Impersonator
A woman in Georgia has filed a police report after an online scammer claiming to be Alan Jackson swindled her out of nearly ...
Actio Biosciences Expands Leadership Team with Appointment of Cayce Denton as Chief Financial Officer
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop ...
Le Lézard2d
Alesta Therapeutics Raises ?65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases
Alesta Therapeutics, a biotechnology company focused on developing transformative small molecule therapies for rare diseases, today announced the closing of an oversubscribed ?65 million Series ...
Le Lézard2d
1cBio and Alesta Therapeutics Announce Exclusive Global Licensing Agreement for a Novel Potentially First-in-Class Small Molecule for Hypophosphatasia
Bio, Inc. ("1cBio") an emerging biotech company developing precision medicines for significant unmet needs, and Alesta Pharmaceuticals ("Alesta") a leader in developing first-in-class small molecules ...
Pharmabiz3d
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease
US FDA grants orphan drug designation to NMD Pharma’s NMD670 to treat patients with Charcot-Marie-tooth disease: Aarhus, Denmark Tuesday, January 7, 2025, 16:00 Hrs [IST] NMD Ph ...
FierceBiotech4d
Fierce Biotech Fundraising Tracker '25: Kardigan launches with $300M; Windward wins $200M
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. | The Fierce Biotech Fundraising Tracker records ...
FDA grants ODD to NMD Pharma’s Charcot-Marie-Tooth disease therapy
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development ...
manilatimes4d
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
Immunocore to present at the 43 rd Annual J.P. Morgan Healthcare Conference ...
NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease
NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2nd ...
Pharmaceutical Technology11d
CKD-510 by Novartis for Charcot-Marie-Tooth Disease: Likelihood of Approval
CKD-510 is under development for the treatment of Charcot-Marie-Tooth disease and atrial fibrillation. It is administered through oral route.The drug candidate is a new chemical entity targeting ...